RestoriT-001: Treatment of erectile dysfunction post prostatectomy

• Research type

  Research Study

• Full title

  An open label, pilot study to determine the effect of weekly intra-cavernosal injections of Invicorp on male Erectile Dysfunction (ED) post radical prostatectomy

• IRAS ID

  310426

• Contact name

  Brian Leaker

• Contact email

  brian.leaker@heartlungcentre.com

• Sponsor organisation

  RestoriT Ltd

• Eudract number

  2021-005456-11

• ISRCTN Number

  ISRCTN77251669

• Duration of Study in the UK

  0 years, 5 months, 31 days

• Research summary

  This study is An open label, pilot study to determine the effect of in-centre and at-home administration intra-cavernosal injections of Invicorp 25mcg/2mg on male Erectile Dysfunction (ED) post radical prostatectomy.

  To determine the efficacy of Intra-cavernosal Invicorp for Erectile Dysfunction pre and post radical prostatectomy as determined by the sexual function questionnaire, International Index of Erectile Function (IIEF-15).

• REC name

  London - London Bridge Research Ethics Committee

• REC reference

  22/LO/0048

• Date of REC Opinion

  10 Mar 2022

• REC opinion

  Further Information Favourable Opinion